Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2011

Open Access 01-12-2011 | Case report

Low back pain as the presenting sign in a patient with primary extradural melanoma of the thoracic spine - A metastatic disease 17 Years after complete surgical resection

Authors: Darko Katalinic, Branimir Anic, Ranka Stern-Padovan, Miroslav Mayer, Mirna Sentic, Nada Cikes, Kamelija Zarkovic, Snjezana Dotlic, Stjepko Plestina

Published in: World Journal of Surgical Oncology | Issue 1/2011

Login to get access

Abstract

Primary spinal melanomas are extremely rare lesions. In 1906, Hirschberg reported the first primary spinal melanoma, and since then only 40 new cases have been reported. A 47-year-old man was admitted suffering from low back pain, fatigue and loss of body weight persisting for three months. He had a 17-year-old history of an operated primary spinal melanoma from T7-T9, which had remained stable for these 17 years. Routine laboratory findings and clinical symptoms aroused suspicion of a metastatic disease. Multislice computed tomography and magnetic resonance imaging revealed stage-IV melanoma with thoracic, abdominal and skeletal metastases without the recurrence of the primary process. Transiliac crest core bone biopsy confirmed the diagnosis of metastatic melanoma. It is important to know that in all cases of back ore skeletal pain and unexplained weight loss, malignancy must always be considered in the differential diagnosis, especially in the subjects with a positive medical history. Patients who have back, skeletal, or joint pain that is unresponsive to a few weeks of conservative treatment or have known risk factors with or without serious etiology, are candidates for imaging studies. The present case demonstrates that complete surgical resection alone may result in a favourable outcome, but regular medical follow-up for an extended period, with the purpose of an early detection of a metastatic disease, is highly recommended.
Appendix
Available only for authorised users
Literature
2.
go back to reference Kounin GK, Romansky KV, Traykov LD, Shotekov PM, Stoilova DZ: Primary spinal melanoma with bilateral papilledema. Clin Neurol Neurosurg. 2005, 107: 525-527. 10.1016/j.clineuro.2004.10.013.CrossRefPubMed Kounin GK, Romansky KV, Traykov LD, Shotekov PM, Stoilova DZ: Primary spinal melanoma with bilateral papilledema. Clin Neurol Neurosurg. 2005, 107: 525-527. 10.1016/j.clineuro.2004.10.013.CrossRefPubMed
3.
go back to reference Naing A, Messina JL, Vrionis FR, Daud AI: Uncommon manifestations of common malignancies: case 3. Malignant melanoma arising from a spinal nerve root. J Clin Oncol. 2004, 22: 3194-3195. 10.1200/JCO.2004.09.021.CrossRefPubMed Naing A, Messina JL, Vrionis FR, Daud AI: Uncommon manifestations of common malignancies: case 3. Malignant melanoma arising from a spinal nerve root. J Clin Oncol. 2004, 22: 3194-3195. 10.1200/JCO.2004.09.021.CrossRefPubMed
4.
go back to reference Brat DJ, Giannini C, Scheithauer BW, Burger PC: Primary melanocytic neoplasms of the central nervous system. Am J Surg Pathol. 1999, 23: 745-754. 10.1097/00000478-199907000-00001.CrossRefPubMed Brat DJ, Giannini C, Scheithauer BW, Burger PC: Primary melanocytic neoplasms of the central nervous system. Am J Surg Pathol. 1999, 23: 745-754. 10.1097/00000478-199907000-00001.CrossRefPubMed
6.
go back to reference Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, Begg CB, Agarwala SS, Schuchter LM, Ernstoff MS, Houghton AN, Kirkwood JM: Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma. J Clin Oncol. 1999, 17: 2745-2751.PubMed Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, Begg CB, Agarwala SS, Schuchter LM, Ernstoff MS, Houghton AN, Kirkwood JM: Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma. J Clin Oncol. 1999, 17: 2745-2751.PubMed
7.
go back to reference Yamasaki T, Kikuchi H, Yamaschita J, Asato R, Fujita M: Primary spinal intramedullary malignant melanoma: case report. Neurosurgery. 1989, 25: 117-121. 10.1227/00006123-198907000-00023.CrossRefPubMed Yamasaki T, Kikuchi H, Yamaschita J, Asato R, Fujita M: Primary spinal intramedullary malignant melanoma: case report. Neurosurgery. 1989, 25: 117-121. 10.1227/00006123-198907000-00023.CrossRefPubMed
8.
go back to reference Farrokh D, Fransen P, Faverly D: MR findings of a primary intramedullary malignant melanoma: case report and literature review. Am J Neuroradiol. 2001, 22: 1864-1866.PubMed Farrokh D, Fransen P, Faverly D: MR findings of a primary intramedullary malignant melanoma: case report and literature review. Am J Neuroradiol. 2001, 22: 1864-1866.PubMed
9.
go back to reference Larson TC, Houser OW, Onofrio BM, Peipgras DG: Primary spinal melanoma. J Neurosurg. 1987, 66: 47-49. 10.3171/jns.1987.66.1.0047.CrossRefPubMed Larson TC, Houser OW, Onofrio BM, Peipgras DG: Primary spinal melanoma. J Neurosurg. 1987, 66: 47-49. 10.3171/jns.1987.66.1.0047.CrossRefPubMed
10.
go back to reference Isiklar I, Leeds NE, Fuller GN, Kumar AJ: Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content. Am J Roentgenol. 1995, 165: 1503-1512.CrossRef Isiklar I, Leeds NE, Fuller GN, Kumar AJ: Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content. Am J Roentgenol. 1995, 165: 1503-1512.CrossRef
11.
go back to reference Woodruff WW, Djang WT, McLendon RE, Heinz ER, Voorhees DR: Intracerebral malignant melanoma: high-field-strength MR imaging. Radiology. 1987, 165: 209-213.CrossRefPubMed Woodruff WW, Djang WT, McLendon RE, Heinz ER, Voorhees DR: Intracerebral malignant melanoma: high-field-strength MR imaging. Radiology. 1987, 165: 209-213.CrossRefPubMed
12.
go back to reference Fon GT, Wong WS, Gold RH, Kaiser LR: Skeletal metastases of melanoma: radiographic, scintigraphic, and clinical review. Am J Roentgenol. 1981, 137: 103-108.CrossRef Fon GT, Wong WS, Gold RH, Kaiser LR: Skeletal metastases of melanoma: radiographic, scintigraphic, and clinical review. Am J Roentgenol. 1981, 137: 103-108.CrossRef
13.
go back to reference Edelstyn GA, Gillespie PJ, Grebell ES: The radiologic demonstration of osseous metastases: experimental observations. Clin Radiol. 1967, 18: 158-164. 10.1016/S0009-9260(67)80010-2.CrossRefPubMed Edelstyn GA, Gillespie PJ, Grebell ES: The radiologic demonstration of osseous metastases: experimental observations. Clin Radiol. 1967, 18: 158-164. 10.1016/S0009-9260(67)80010-2.CrossRefPubMed
14.
go back to reference Patten RM, Shuman WP, Teefey S: Metastases from malignant melanoma to the axial skeleton: a CT study of frequency and appearance. Am J Roentgenol. 1990, 155: 109-112.CrossRef Patten RM, Shuman WP, Teefey S: Metastases from malignant melanoma to the axial skeleton: a CT study of frequency and appearance. Am J Roentgenol. 1990, 155: 109-112.CrossRef
15.
go back to reference Finger PT, Kurli M, Wesley P, Tena L, Kerr KR, Pavlick A: Whole body PET/CT imaging for detection of metastatic choroidal melanoma. Br J Ophthalmol. 2004, 88: 1095-1097. 10.1136/bjo.2003.039289.PubMedCentralCrossRefPubMed Finger PT, Kurli M, Wesley P, Tena L, Kerr KR, Pavlick A: Whole body PET/CT imaging for detection of metastatic choroidal melanoma. Br J Ophthalmol. 2004, 88: 1095-1097. 10.1136/bjo.2003.039289.PubMedCentralCrossRefPubMed
16.
17.
go back to reference Rate WR, Solin LJ, Turrisi AT: Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression. Int J Radiot Oncol Biol Phys. 1988, 15: 859-864. 10.1016/0360-3016(88)90118-6.CrossRef Rate WR, Solin LJ, Turrisi AT: Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression. Int J Radiot Oncol Biol Phys. 1988, 15: 859-864. 10.1016/0360-3016(88)90118-6.CrossRef
18.
go back to reference Herbert SH, Solin Lj, Rate WR, Schultz DJ, Hanks GE: The effect of palliative radiation therapy on epidural compression due to metastatic malignant melanoma. Cancer. 1991, 67: 2472-2476. 10.1002/1097-0142(19910515)67:10<2472::AID-CNCR2820671014>3.0.CO;2-V.CrossRefPubMed Herbert SH, Solin Lj, Rate WR, Schultz DJ, Hanks GE: The effect of palliative radiation therapy on epidural compression due to metastatic malignant melanoma. Cancer. 1991, 67: 2472-2476. 10.1002/1097-0142(19910515)67:10<2472::AID-CNCR2820671014>3.0.CO;2-V.CrossRefPubMed
19.
go back to reference Cooper JS: The evolution of the role of radiation therapy in the management of mucocutaneous malignant melanoma. Hematol Oncol Clin North Am. 1998, 12: 849-862. 10.1016/S0889-8588(05)70027-7.CrossRefPubMed Cooper JS: The evolution of the role of radiation therapy in the management of mucocutaneous malignant melanoma. Hematol Oncol Clin North Am. 1998, 12: 849-862. 10.1016/S0889-8588(05)70027-7.CrossRefPubMed
20.
go back to reference Geara FB, Ang KK: Radiation therapy for malignant melanoma. Surg Clin North Am. 1996, 76: 1383-1398. 10.1016/S0039-6109(05)70521-1.CrossRefPubMed Geara FB, Ang KK: Radiation therapy for malignant melanoma. Surg Clin North Am. 1996, 76: 1383-1398. 10.1016/S0039-6109(05)70521-1.CrossRefPubMed
21.
go back to reference Hamilton AJ, Lulu BA, Fosmire H, Stea B, Cassady JR: Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery. 1995, 36: 311-319. 10.1227/00006123-199502000-00010.CrossRefPubMed Hamilton AJ, Lulu BA, Fosmire H, Stea B, Cassady JR: Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery. 1995, 36: 311-319. 10.1227/00006123-199502000-00010.CrossRefPubMed
22.
go back to reference Gerszten PC: The role of minimally invasive techniques in the management of spine tumors: percutaneous bone cement augmentation, radiosurgery, and microendoscopic approaches. Orthop Clin North Am. 2007, 38: 441-450. 10.1016/j.ocl.2007.03.004.CrossRefPubMed Gerszten PC: The role of minimally invasive techniques in the management of spine tumors: percutaneous bone cement augmentation, radiosurgery, and microendoscopic approaches. Orthop Clin North Am. 2007, 38: 441-450. 10.1016/j.ocl.2007.03.004.CrossRefPubMed
23.
go back to reference Gerszten PC, Ozhasoglu C, Burton SA, Vogel WJ, Atkins BA, Kalnicki S, Welch WC: CyberKnife frameless stereotactic radiosurgery for spinal lesions: clinical experience in 125 cases. Neurosurgery. 2004, 55: 89-99.PubMed Gerszten PC, Ozhasoglu C, Burton SA, Vogel WJ, Atkins BA, Kalnicki S, Welch WC: CyberKnife frameless stereotactic radiosurgery for spinal lesions: clinical experience in 125 cases. Neurosurgery. 2004, 55: 89-99.PubMed
24.
go back to reference Falkson CI, Ibrahim J, Kirkwood JM, Coates AS, Atkins MB, Blum RH: Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol. 1998, 16: 1743-1751.PubMed Falkson CI, Ibrahim J, Kirkwood JM, Coates AS, Atkins MB, Blum RH: Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study. J Clin Oncol. 1998, 16: 1743-1751.PubMed
25.
go back to reference Demchak PA, Mier JW, Robert NJ, O'Brien K, Gould JA, Atkins MB: Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: a pilot study. J Clin Oncol. 1991, 9: 1821-1830.PubMed Demchak PA, Mier JW, Robert NJ, O'Brien K, Gould JA, Atkins MB: Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: a pilot study. J Clin Oncol. 1991, 9: 1821-1830.PubMed
26.
go back to reference Flaherty LE, Robinson W, Redman BG, Gonzalez R, Martino S, Kraut M, Valdivieso M, Rudolph AR: A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma. Cancer. 1993, 71: 3520-3525. 10.1002/1097-0142(19930601)71:11<3520::AID-CNCR2820711110>3.0.CO;2-A.CrossRefPubMed Flaherty LE, Robinson W, Redman BG, Gonzalez R, Martino S, Kraut M, Valdivieso M, Rudolph AR: A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma. Cancer. 1993, 71: 3520-3525. 10.1002/1097-0142(19930601)71:11<3520::AID-CNCR2820711110>3.0.CO;2-A.CrossRefPubMed
27.
go back to reference Atkins MB, O'Boyle KR, Sosman JA, Weiss GR, Margolin KA, Ernest ML, Kappler K, Mier JW, Sparano JA, Fisher RI: Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma. J Clin Oncol. 1994, 12: 1553-1560.PubMed Atkins MB, O'Boyle KR, Sosman JA, Weiss GR, Margolin KA, Ernest ML, Kappler K, Mier JW, Sparano JA, Fisher RI: Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma. J Clin Oncol. 1994, 12: 1553-1560.PubMed
28.
go back to reference Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Seipp CA, Einhorn JH, White DE, Steinberg SM: Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b. J Clin Oncol. 1999, 17: 968-975.PubMed Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Seipp CA, Einhorn JH, White DE, Steinberg SM: Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b. J Clin Oncol. 1999, 17: 968-975.PubMed
29.
go back to reference Huncharek M, Caubet JF, McGarry R: Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials. Melanoma Res. 2001, 11: 75-81. 10.1097/00008390-200102000-00009.CrossRefPubMed Huncharek M, Caubet JF, McGarry R: Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials. Melanoma Res. 2001, 11: 75-81. 10.1097/00008390-200102000-00009.CrossRefPubMed
30.
go back to reference Wöll E, Bedikian A, Legha SS: Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res. 1999, 9: 575-581. 10.1097/00008390-199912000-00006.CrossRefPubMed Wöll E, Bedikian A, Legha SS: Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res. 1999, 9: 575-581. 10.1097/00008390-199912000-00006.CrossRefPubMed
31.
go back to reference O'Day SJ, Kim CJ, Reintgen DS: Metastatic Melanoma: Chemotherapy to Biochemotherapy. Cancer Control. 2002, 9: 31-38.PubMed O'Day SJ, Kim CJ, Reintgen DS: Metastatic Melanoma: Chemotherapy to Biochemotherapy. Cancer Control. 2002, 9: 31-38.PubMed
32.
go back to reference O'Day SJ, Atkins MB, Boasberg P, Wang HJ, Thompson JA, Anderson CM, Gonzalez R, Lutzky J, Amatruda T, Hersh EM, Weber JS: Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma. J Clin Oncol. 2009, 27: 6207-6212. 10.1200/JCO.2008.20.3075.CrossRefPubMed O'Day SJ, Atkins MB, Boasberg P, Wang HJ, Thompson JA, Anderson CM, Gonzalez R, Lutzky J, Amatruda T, Hersh EM, Weber JS: Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma. J Clin Oncol. 2009, 27: 6207-6212. 10.1200/JCO.2008.20.3075.CrossRefPubMed
33.
go back to reference Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, Duray PH, Steinberg SM, Allison JP, Davis TA, Rosenberg SA: Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA. 2003, 100: 8372-8377. 10.1073/pnas.1533209100.PubMedCentralCrossRefPubMed Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, Duray PH, Steinberg SM, Allison JP, Davis TA, Rosenberg SA: Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA. 2003, 100: 8372-8377. 10.1073/pnas.1533209100.PubMedCentralCrossRefPubMed
34.
go back to reference Robert C, Thomas L, Bondarenko I, O'Day S, MD JW, Garbe C, Lebbe C, Baurain JF, Testori A, Grob JJ, Davidson N, Richards J, Maio M, Hauschild A, Miller WH, Gascon P, Lotem M, Harmankaya K, Ibrahim R, Francis S, Chen TT, Humphrey R, Hoos A, Wolchok JD: Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011, 364: 2517-2526. 10.1056/NEJMoa1104621.CrossRefPubMed Robert C, Thomas L, Bondarenko I, O'Day S, MD JW, Garbe C, Lebbe C, Baurain JF, Testori A, Grob JJ, Davidson N, Richards J, Maio M, Hauschild A, Miller WH, Gascon P, Lotem M, Harmankaya K, Ibrahim R, Francis S, Chen TT, Humphrey R, Hoos A, Wolchok JD: Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011, 364: 2517-2526. 10.1056/NEJMoa1104621.CrossRefPubMed
35.
go back to reference Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010, 363: 711-23. 10.1056/NEJMoa1003466.PubMedCentralCrossRefPubMed Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010, 363: 711-23. 10.1056/NEJMoa1003466.PubMedCentralCrossRefPubMed
36.
go back to reference Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA, BRIM-3 Study Group: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011, 364: 2507-2516. 10.1056/NEJMoa1103782.PubMedCentralCrossRefPubMed Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA, BRIM-3 Study Group: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011, 364: 2507-2516. 10.1056/NEJMoa1103782.PubMedCentralCrossRefPubMed
37.
go back to reference Machet L, Perrinaud A, Giraudeau B: Routine ultrasonography in melanoma follow-up?. The Lancet Oncology. 2005, 6: 2-CrossRefPubMed Machet L, Perrinaud A, Giraudeau B: Routine ultrasonography in melanoma follow-up?. The Lancet Oncology. 2005, 6: 2-CrossRefPubMed
38.
go back to reference DiFronzo LA, Wanek LA, Morton DL: Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up. Cancer. 2001, 91: 1520-1524. 10.1002/1097-0142(20010415)91:8<1520::AID-CNCR1160>3.0.CO;2-6.CrossRefPubMed DiFronzo LA, Wanek LA, Morton DL: Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up. Cancer. 2001, 91: 1520-1524. 10.1002/1097-0142(20010415)91:8<1520::AID-CNCR1160>3.0.CO;2-6.CrossRefPubMed
Metadata
Title
Low back pain as the presenting sign in a patient with primary extradural melanoma of the thoracic spine - A metastatic disease 17 Years after complete surgical resection
Authors
Darko Katalinic
Branimir Anic
Ranka Stern-Padovan
Miroslav Mayer
Mirna Sentic
Nada Cikes
Kamelija Zarkovic
Snjezana Dotlic
Stjepko Plestina
Publication date
01-12-2011
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2011
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-9-150

Other articles of this Issue 1/2011

World Journal of Surgical Oncology 1/2011 Go to the issue